Regulus Therapeutics Inc. 4/A SEC Filings

Filed On	Filing
17 Jan 2023	Form 4/A: Aker Christopher Ray, Sr. VP & General Counsel Granted 45,000 Stock Option (Right to Buy)
16 Apr 2021	Form 4/A: Hagan Joseph P, Director Sold 4,144 shares ($7.13K)
27 Jan 2021	Form 4/A: Papadopoulos Stelios, Director Received 793,528 shares as a grant or award ($500K)
21 May 2019	Form 4/A: Papadopoulos Stelios, Director Received 370,370 shares as a grant or award ($400K) · Granted 370,370 Common Stock Purchase Warrant (Right to Buy) ($46.3K)
21 May 2019	Form 4/A: Rastetter William H, Director Received 92,889 shares as a grant or award ($100K) · Granted 92,889 Common Stock Purchase Warrant (Right to Buy) ($11.6K)
21 May 2019	Form 4/A: Witz Pascale, Director Received 29,630 shares as a grant or award ($32K) · Granted 29,630 Common Stock Purchase Warrant (Right to Buy) ($3.7K)
21 May 2019	Form 4/A: Hagan Joseph P, Director Received 33,194 shares as a grant or award ($35.8K) · Granted 33,194 Common Stock Purchase Warrant (Right to Buy) ($4.15K)
16 May 2019	Form 4/A: Chevallard Daniel R., Chief Financial Officer Granted 8,000 Stock Option (Right to Buy)
10 May 2019	Form 4/A: Walker Paul Edward, 10% owner Bought 1,136,704 shares ($1.23M) · Acquired 3,703,704 Common Stock Purchase Warrant (Right to Buy) (Open Market Purchase) ($463K) · Acquired 256,700 Class A-1 Convertible Preferred Stock (Open Market Purchase) ($2.77M)
28 Oct 2014	Form 4/A: Isis Pharmaceuticals Inc, Director Sold 109,534 shares ($1.53M) · Sold 1,700 shares ($24.2K) · Sold 1,850 shares ($28.1K)
28 Oct 2014	Form 4/A: Alnylam PHARMACEUTICALS, Inc., 10% owner Sold 109,534 shares ($1.53M) · Sold 1,700 shares ($24.2K) · Sold 1,850 shares ($28.1K)
18 Jun 2014	Form 4/A: Gibson Neil W, Chief Scientific Officer Exercised 2,500 Stock Option (Right to Buy)
18 Jun 2014	Form 4/A: Gibson Neil W, Chief Scientific Officer Exercised 2,500 Stock Option (Right to Buy)

Comments